Earnings Labs
BioCryst Pharmaceuticals, Inc. logo

BioCryst Pharmaceuticals, Inc. (BCRX) Earnings

NASDAQ·Healthcare·Biotechnology

$8.89

-0.17%

Mkt Cap $1.80B

Next Earnings

In 7 days

Wed, May 6, 2026

EPS Estimate

$0.06

3 analysts

Revenue Estimate

$151.12M

Last quarter: beat by +1500.00% on EPS, +168.66% on revenue.

EPS — Estimate vs Actual

Mkt Cap

$1.80B

P/E

7.47

Fwd P/E

32.82

P/S

2.06

Rev TTM

EPS TTM

$1.20